deutetrabenazine for the treatment of chorea associated with Huntington’s disease
This is a comprehensive review of the literature regarding the use of Deutetrabenazine in treating chorea associated with Huntington’s disease. Unfortunately, treatment has been limited for many aspects of this neurodegenerative disease. The present investigation presents the background, evidence, a...
Saved in:
| Main Authors: | Harshit Gupta, Wil Perkins, Cain Stark, Sathya Kikkeri, Juyeon Kakazu, Adam D. Kaye, Alan D. Kaye |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Medical Publishing
2022-06-01
|
| Series: | Health Psychology Research |
| Online Access: | https://doi.org/10.52965/001c.36040 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease
by: Samuel Frank, et al.
Published: (2024-09-01) -
Glossopharyngeal Neuralgia: Epidemiology, Risk factors, Pathophysiology, Differential diagnosis, and Treatment Options
by: Andrew Han, et al.
Published: (2022-06-01) -
pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy
by: Noeen Sarfraz, et al.
Published: (2022-05-01) -
Longitudinal Treatment Patterns of Chorea in North American Patients with Huntington’s Disease: Data from Enroll-HD
by: Erin Furr Stimming, et al.
Published: (2025-01-01) -
Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington’s Disease–associated Chorea Initiated on Tetrabenazine
by: Victor W. Sung, et al.
Published: (2018-01-01)